At Novocure, we're driven by a clear mission: to extend survival in some of the most aggressive forms of cancer through our innovative TTFields therapy. We are looking for a highly motivated, entrepreneurial Key Account Manager to support further growth of our presence across Austria, expand patient access to the therapy, and build lasting partnerships within the oncology community.
As the Key Account Manager, you will be responsible for growing acceptance and awareness of TTFields therapy as the standard of care in certain cancer types. You will fully own the process of developing Optune accounts in the region, starting with identifying high-potential accounts, converting them into TTFields centers of reference, and developing your ability to successfully prescribe TTFields to patients.
You will play a key role in interactions with all key stakeholders in the region, and act as face of Novocure towards them.
This is a unique opportunity to join a growing organization and play a critical role in shaping Novocure's success in Austria while making a meaningful difference in the lives of patients.
Preferred candidate location: Styria, Carinthia, or Upper Austria. This is a field-based role requiring extensive travel (80-90%) across Austria and occasional travel within Europe.
Interested? Apply today and join us! We are looking forward to receive your application to Emilia Bagińska, Senior Talent Acquisition Partner through our Applicant Portal.
Please find more information about Novocure and our therapy on our website www.novocure.

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer.
Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.